Correlation Between Transcode Therapeutics and Sparta Capital
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Sparta Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Sparta Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Sparta Capital, you can compare the effects of market volatilities on Transcode Therapeutics and Sparta Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Sparta Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Sparta Capital.
Diversification Opportunities for Transcode Therapeutics and Sparta Capital
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Transcode and Sparta is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Sparta Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sparta Capital and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Sparta Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sparta Capital has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Sparta Capital go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Sparta Capital
Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Sparta Capital. In addition to that, Transcode Therapeutics is 1.13 times more volatile than Sparta Capital. It trades about -0.41 of its total potential returns per unit of risk. Sparta Capital is currently generating about -0.22 per unit of volatility. If you would invest 1.96 in Sparta Capital on August 28, 2024 and sell it today you would lose (0.46) from holding Sparta Capital or give up 23.47% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Transcode Therapeutics vs. Sparta Capital
Performance |
| Timeline |
| Transcode Therapeutics |
| Sparta Capital |
Transcode Therapeutics and Sparta Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and Sparta Capital
The main advantage of trading using opposite Transcode Therapeutics and Sparta Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Sparta Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sparta Capital will offset losses from the drop in Sparta Capital's long position.| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
| Sparta Capital vs. Copa Holdings SA | Sparta Capital vs. United Airlines Holdings | Sparta Capital vs. Delta Air Lines | Sparta Capital vs. SkyWest |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |